Pharmosa Biopharm Inc. (PBI) is a world-class biotechnology company focusing on developing a new drug by exploiting our proprietary formulation and manufacturing technology. With regional/global strategic partnerships, we commercialize our product through 505(b)2 or hybrid applications to regulatory authorities.
We strive for excellence in order to improve quality of life for people through innovation and sustained quality.
We expand the potential of existing drugs by exploiting innovative delivery formulations and medical devices, then bringing the combined medicines to patients and healthcare providers.
Infinite imagination and creativity through teamwork
Efficient execution of every project with sustained quality.
Enterprise growth from a basis of listening, understanding, and care for patients.